International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-1 doi: 10.5281/zenodo.10609026
Original Article
Study of Correlation Between Highly Sensitive C-Reactive Protein, Serum Triglyceride Level with CIMT In Asymptomatic T2DM Patients with Their Level of Sugar Control
 ,
 ,
 ,
Published
Jan. 31, 2024
Abstract

Background: Type 2 diabetes mellitus (T2DM) patients with uncontrolled sugar are at increased risk of atherosclerosis as compared to diabetic patients with controlled sugar. Detecting atherosclerosis in its subclinical stages can potentially impede or mitigate the development of complications such as coronary artery diseases, stroke, and peripheral vascular diseases. Early identification offers the opportunity to implement interventions that may slow down the progression of the disease and reduce the risk of atherosclerotic-related complications.

Objective: Identification of subclinical atherosclerosis in controlled and uncontrolled diabetic patients and explore various factors [highly sensitive C-reactive protein (hs-CRP) and triglyceride (TG)] that can be associated with a high risk of subclinical atherosclerosis.

Patients and methods: We recruited 60 known case of T2DM patients without any clinically manifested disease and without any past history of a vascular disease. Those patients were divided into two equal groups, well controlled and uncontrolled based on their HbA1c. After complete history and physical examination, investigations including serum triglyceride (TG), hs-CRP, fasting and 2 hours postprandial blood glucose were obtained. All participants underwent for measurement of carotid intima media thickness (CIMT),marker of subclinical atherosclerosis by duplex ultrasonography.

Results: Uncontrolled diabetic patients have increased CIMT (6.9394mm) as compared to controlled diabetic patients (.8181mm). There was highly significant positive correlation between CIMT and hs-CRP in uncontrolled diabetic group (p value .001, r value .469) but no association within controlled diabetic group ( p value .074 and r value was .244) . While significant positive correlation with CIMT and TG level in controlled diabetic group (p value <.001 and r value was .689) and no correlation between CIMT and TG level in uncontrolled diabetic group (p = .195 , r = .175).

Conclusion: The risk of subclinical atherosclerosis is more in uncontrolled diabetics as compared to controlled diabetics. In uncontrolled diabetics subclinical atherosclerosis was associated with elevated hs-CRP level and in controlled diabetic CIMT was associated with elevated serum TG levels

Recommended Articles
Loading Image...
Volume-5, Issue-1
Citations
1445 Views
360 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved